205 Although confirmation in an RCT would be desirable, these findings provide reassurance regarding the use of ECMO in a select population of patients with severe COVID-19
When administered in humans, GIP receptor antagonists conjugated to GLP-1 analogues have led to mild gastrointestinal-related adverse events, including nausea and vomiting (50)
In most reports, fewer than a handful of severe side effects were documented across treatment groups, and there was no significant imbalance compared with placebo arms
F., Leggio, L., & Farokhnia, M
Cons: I'm lactose intolerant and it makes my bloating a little worse with dairy, but it goes away once I take a bowel movement
Track symptoms in relation to injections, dose changes, meals, bowel movements, and hydration